moxifloxacin has been researched along with Chronic Illness in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (56.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J | 1 |
| Ishikawa, T; Kitaya, K; Sakuraba, Y; Tanaka, SE | 1 |
| Blanco, C; Núñez, MX | 1 |
| den Broeder, AA; Nabuurs-Franssen, M; Schoffelen, T; Sprong, T; van Deuren, M | 1 |
| Magri, V; Marras, E; Perletti, G; Restelli, A | 1 |
| Jones, PW; Miravitlles, M; Rubinstein, E; Sethi, S; Theron, MS; Wedzicha, JA; Wilson, R | 1 |
| Cakici, H; Guven, M; Kocoglu, E; Ozturan, KE; Yucel, I | 1 |
| Barker, EN; Chalker, VJ; Hamon, M; Jensen, J; Mitchell, J; Steer, JA; Stocki, T; Tasker, S | 1 |
| Fu, L; Jin, H; Li, P; Lu, Y; Mdluli, K; Upton, AM; Wang, B; Xu, J; Zhao, W; Zheng, M; Zhu, H | 1 |
| Macklin-Doherty, A; Wilson, R | 1 |
| Andersen, AB; Iversen, M; Katzenstein, TL; Lillebaek, T; Mared, L; Qvist, T | 1 |
| Dinis, PB; Martins, ML; Monteiro, MC; Morais, JG; Silva, N | 1 |
| Wilson, R | 1 |
| Aimoni, C; Cassetta, MI; D'Errico, G; Esposito, S; Fallani, S; Mazzei, T; Motta, G; Novelli, A; Noviello, S; Passali, D; Pilucchi, S | 1 |
| Anzueto, A; Choudhri, S; Haverstock, D; Kureishi, A; Niederman, MS; Perroncel, R; Sethi, S | 1 |
| Brosa, M; Miravitlles, M; Molina, J | 1 |
| Drewe, E; McDermott, EM; Powell, RJ | 1 |
| Groeneveld, JH; Kuijper, EJ; van Nieuwkoop, C; Visser, LG | 1 |
| Aneiro, L; Chodosh, S; Church, D; DeAbate, CA; Haverstock, D | 1 |
| Busch, W; Lorenz, J; Thate-Waschke, IM | 1 |
| Ball, P | 1 |
| Church, D; DeAbate, CA; Heyd, A; Mathew, CP; Warner, JH | 1 |
| Cobos, A; Kubin, R; Miravitlles, M; Ros, F; Tillotson, G | 1 |
| Garau, J; Lode, H | 1 |
| Sidorenko, SV | 1 |
5 review(s) available for moxifloxacin and Chronic Illness
| Article | Year |
|---|---|
The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Bronchitis; Chronic Disease; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines | 2012 |
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
[Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis].
Topics: Anti-Bacterial Agents; Aza Compounds; Bronchitis; Chronic Disease; Clinical Trials as Topic; Comorbidity; Double-Blind Method; Drug Evaluation; Fluoroquinolones; Forced Expiratory Volume; Humans; Middle Aged; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Treatment Outcome | 2007 |
Improving care for patients with respiratory tract infections.
Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Patient Satisfaction; Pneumonia; Quality of Health Care; Quinolines; Sinusitis | 2002 |
[Perspectives of use of moxifloxacin for treatment of urogenital infections].
Topics: Anti-Infective Agents; Aza Compounds; Chronic Disease; Clinical Trials as Topic; Female Urogenital Diseases; Fluoroquinolones; Humans; Male Urogenital Diseases; Moxifloxacin; Quinolines | 2002 |
7 trial(s) available for moxifloxacin and Chronic Illness
| Article | Year |
|---|---|
Multi-drug-resistant chronic endometritis in infertile women with repeated implantation failure: trend over the decade and pilot study for third-line oral antibiotic treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Chronic Disease; Embryo Implantation; Endometritis; Endometrium; Female; Humans; Infertility, Female; Moxifloxacin; Pharmaceutical Preparations; Pilot Projects; Prospective Studies; Retrospective Studies | 2022 |
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Placebo Effect; Pulmonary Disease, Chronic Obstructive; Quinolines; Secondary Prevention; Treatment Outcome | 2010 |
Sinus tissue concentration of moxifloxacin after a single oral dose.
Topics: Administration, Oral; Adult; Age Factors; Aged; Anti-Infective Agents; Aza Compounds; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Nasal Mucosa; Paranasal Sinuses; Quinolines; Rhinitis; Sinusitis | 2004 |
Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Palatine Tonsil; Plasma; Quinolines; Recurrence; Tonsillectomy; Tonsillitis | 2006 |
Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Treatment Outcome | 2000 |
The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Prospective Studies; Quinolines | 2000 |
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.
Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Treatment Outcome | 2001 |
13 other study(ies) available for moxifloxacin and Chronic Illness
| Article | Year |
|---|---|
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological Availability; Chronic Disease; DNA Gyrase; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Macrophages; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Piperidines; Protein Subunits; Rats; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis, Pulmonary | 2014 |
Antibiotic susceptibility of staphylococci isolates from patients with chronic conjunctivitis: including associated factors and clinical evaluation.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Conjunctivitis, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2013 |
Acute and probable chronic Q fever during anti-TNFα and anti B-cell immunotherapy: a case report.
Topics: Aged; Antibodies; Antibodies, Bacterial; Arthritis, Rheumatoid; B-Lymphocytes; Chronic Disease; Coxiella burnetii; Doxycycline; Fluoroquinolones; Humans; Immunity, Cellular; Immunity, Humoral; Immunotherapy; Male; Moxifloxacin; Q Fever; Tumor Necrosis Factor-alpha | 2014 |
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Moxifloxacin; Peptostreptococcus; Prostatitis; Quinolines; Treatment Outcome | 2010 |
Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Disease Models, Animal; Fluoroquinolones; Injections, Intraperitoneal; Male; Moxifloxacin; Osteomyelitis; Prosthesis-Related Infections; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Treatment Outcome | 2010 |
A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Cluster Analysis; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Female; Fever; Fluoroquinolones; Humans; Middle Aged; Molecular Sequence Data; Moxifloxacin; Mycoplasma; Mycoplasma Infections; Neutropenia; Phylogeny; Quinolines; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2011 |
In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.
Topics: Animals; Antitubercular Agents; Aza Compounds; Chronic Disease; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Isoniazid; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin; Time Factors; Tuberculosis, Pulmonary | 2012 |
First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Bronchiectasis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Lung Transplantation; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
MOSAIC acronym.
Topics: Acute Disease; Administration, Oral; Aza Compounds; Bronchitis; Chronic Disease; Double-Blind Method; Fluoroquinolones; Moxifloxacin; Multicenter Studies as Topic; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Tablets; Terminology as Topic | 2004 |
Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aza Compounds; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Etanercept; Familial Mediterranean Fever; Female; Fluoroquinolones; Follow-Up Studies; Humans; Immunoglobulin G; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome | 2007 |
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Chronic Disease; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis; Quinolines; Recurrence; Treatment Outcome | 2008 |
[Therapy study of acute exacerbated chronic bronchitis. Quinolone rapidly improves cough and chest pain. BRONCHIMOX Study Group].
Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chest Pain; Chronic Disease; Cough; Drug Administration Schedule; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Treatment Outcome | 2000 |
Moxifloxacin (Avelox): an 8-methoxyquinolone antibacterial with enhanced potency.
Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Streptococcus pneumoniae | 2000 |